NCT00653393已完成1 期
To Compare Bioavailability of Kali Tranylcypromine 10mg Tablets to That of Parnate 10 mg Tablets Under Fasting Conditions.
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 39
- 试验地点
- 1
- 主要终点
- Rate and Extend of Absorption
研究概览
简要总结
To compare the single-dose Bioavailability of Tranylcypromine and Parnate
详细描述
To compare the relative Bioavailability of Tranylcypromine 10 mg tablets with that of PARNATE 10mg tablets in normal,healthy, men and women under fasting conditions
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Subjects will be normal, healthy adult men and women who volunteer to participate.
- •Is the individual healthy, nonsmoking, normal adult man or woman who volunteers to participate?
- •Is s/he at least 18 years of age? Is his/her BMI between 19 and 30, exclusive?
- •Is she willing to avoid pregnancy by abstaining from sexual intercourse, or by the use of barrier methods. (diaphragm, condom, foams/jellies, sponge), and IUD, or has she has been surgically sterile or post- menopausal at least six months prior to entering into the study?
- •Is s/he considered reliable and capable of understanding his/her responsibility and role in the study?
- •Has/s/he provided written informed consent?
- •A no answer to any of the above questions indicates taht the individual is ineligible for enrollment.
排除标准
- •Does the individual have a history of allergy or hypersensitivity to tranylcypromine?
- •Does/ s/he have clinically significant laboratory abnormalities that would interface with the conduct or interpretation of the study or jeopardize his/her safety?
- •Does s/he have significant history or clinical evidence of auto-immune, cardiovascular, gastrointestinal, hematopoietic, hepatic, neurological, ongoing infection, pancreatic, or renal diseases that would interface with the conduct or interpretation of the study or jeopardize his/her safety?
- •Is she nursing?
- •Does s/he have serious psychological illness?
- •Does s/he have significant history ( within the past year) or clinical evidence of alcohol or drug abuse?
- •Does s/he have a positive urine drug screen or saliva alcohol screen, or a positive HIV-1 , or hepatitis B or C screen, or a positive pregnancy test?-Is s/he unable to refrain from the use of alcohol or xanthine-containing foods or beverages during periods beginning 48 hours prior to study drug administration and ending when the alst blood sample has been taken?
- •Is s/he unable to refrain from the ingestion of smoked meat, cheese (except cream cheese and cottage cheese), wine and beer during periods beginning 48 hours prior to study initiation and ending seven days after the last blood sample has been taken in study period two?
- •Has s/he used any prescription drug during the 14-day period prior to study initiation, or any OTC drug during the 72-hour period preceding study initiation?
- •Is s/he unable to refrain from the use of all concomitant medications during the study?
- •Ha s/he donated or lost blood, or participated in a clinical study which involved the with drawl of a large volume of blood (480mL or more), during the six week period preceding study initiation?
- •Has s/he donated an investigational drug during the 30 day period preceding study initiation?
- •A yes answer to any of the above questions indicates that the individual is ineligible for enrollment.
研究组 & 干预措施
A
Experimental
Subjects received Kali product under fasting conditions
干预措施: Tranylcypromine (Drug)
B
Active Comparator
Subjects received Parnate product under fasting conditions
干预措施: Parnate (Drug)
结局指标
主要结局
Rate and Extend of Absorption
时间窗: 24 hours
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A Study to Compare the Bioavailability of Two Tramadol Hydrochloride Tablet Products (50 mg and 200 mg, Respectively) at Steady-state Under Fasting ConditionsHealthy SubjectsPharmacokineticsBioavailabilityNCT00834288Labopharm Inc.26
已完成
1 期
Comparative Bioavailability Study of Extended-release and Immediate-release Trazodone in Healthy Adult VolunteersHealthyNCT00839072Labopharm Inc.24
已完成
1 期
Pharmacokinetics of 3 Formulations of Ibuprofen SuppositoriesHealthyNCT00921830Johnson & Johnson Consumer and Personal Products Worldwide25
已完成
1 期
To Demonstrate the Relative Bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fed and Fasted ConditionsDepressionNCT00913952Sandoz18
已完成
1 期
Comparative Bioavailability of Treprostinil Diethanolamine Manufactured by Two Independent FacilitiesPulmonary Arterial HypertensionNCT01165476United Therapeutics64